# UDENYCA

NDC: 70114-101
Generic name: pegfilgrastim-cbqv
Labeler / Manufacturer: Coherus Oncology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20181102

FDA application: BLA761039

## Active ingredients

- PEGFILGRASTIM: 6 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70114-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70114-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8c290ee-b699-4395-a596-1453d4a4b4eb